MEDICAL COLLEGES REFORM TO ADDRESS ACCESSIBILITY, AFFORDABILITY AND RURAL CHALLENGES Priority given to new trainee candidates who come from rural backgrounds and have relevant experience
With
Jodie Long, CEO
Council of Presidents of Medical Colleges (CPMC)
AUSTRALIAN HEALTH JOURNAL SEGMENT
Filmed in Melbourne | September 2025
The Council of Presidents of Medical Colleges (CPMC) is the peak body for Australia’s specialist medical colleges. CPMC provides a voice in the areas such as workforce issues, quality of healthcare and patient safety, and the education and training of specialist doctors.
Australia’s specialist medical colleges are introducing significant changes to their training selection processes to tackle the ongoing shortage of specialist doctors in rural and remote areas. The Council of Presidents of Medical Colleges (CPMC), in collaboration with the National Rural Health Commissioner, has unveiled new guidelines that prioritise candidates with rural backgrounds and experience during trainee selection.
Associate Professor Sanjay Jeganathan, Chair of CPMC, stated, “Too many rural Australians are waiting too long for specialist care or having to travel vast distances.” Research shows that doctors from rural areas are more likely to return and practice in those communities. The new framework systematically rewards candidates with relevant rural experience, including those who spent their childhood in rural settings, medical students who completed over 12 months of rural placements, and junior doctors who worked in rural hospitals.
The initiative reflects unprecedented collaboration among Australia’s specialist medical colleges, moving from good intentions to systematic change. “Every college will now use consistent definitions and transparent processes,” added A/Prof Jeganathan.
In tandem with these changes, CPMC is reforming its governance structure to better address workforce shortages and access challenges. This revised structure includes a Representative College Council and a separate Board of Directors, promoting agile decision-making and clearer communication with stakeholders. Dr. Jeganathan emphasised the importance of creating a unified voice for specialist doctors to respond effectively to urgent healthcare reforms, enhancing the organisation’s accountability and responsiveness.
Australian Health Journal spoke to CPMC CEO Jodie Long about some of the findings and challenges in the workforce within regional and rural settings and how the new governance structure will support representation of the 16 colleges to Government bodies.
Source: Adapted from CPMC media releases
-
Study on digital tool for pharmacists in aged care
In March 2022, the Australia government announced $350 million of funding over 4 years to employ on-site pharmacists in residential aged care, starting July 2023. In April 2023, the government made changes to the proposed on-site pharmacists, where the new program will now be delivered by and through community pharmacies. Regardless of how the model will be implemented, the goal remains the same – to improve quality use of medicines and medicines safety for aged care residents.
-
Practising to top scope of urology practice, advancing treatment & patient care through research
Michael is a urology nurse practitioner with a special interest in prostate cancer survivorship, and has worked in urology for the past ten years. Michael has completed the Prostate Nursing Care course at Latrobe University, Graduate Certificate of Health with a specialisation in Scheduled Medicines (USQ), and the Master of Nursing (Flinders) to become a Nurse Practitioner in 2024.
As a Urology Nurse Practitioner he divides his time between the Australian Prostate Centre and Western Urology.
-
Taiwanese health and research delegation visit Paratus clinical trial site in Canberra
In late August 2025, a Taiwanese delegation comprising government officials from the Taiwanese FDA, various governmental groups, and physicians and researchers from across Taiwan, visited Paratus Clinical’s trial site in Canberra. Their objective was to explore both the differences and similarities between the clinical research ecosystems of Taiwan and Australia.
